| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22b1673638db2579a1be473ac139f6c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e482dae8f4f767034149618ed513151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a235d5ea68d2fb026a0478e87aa13525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65f43003a51deffe0b1d8103ac12a584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0fee919b25f67af4712af4db7b3381f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65038 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
| filingDate |
2006-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4be14f7680f40aa4760189d05a559ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_807866fa8011f4391706f1652fb0fecd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9894b4bcc3787ad7003f83eb0a115b1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c88d903bd0cb289524c737ee28274271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4634a6bc79e7c94bfb6c5fa2e8eac8e2 |
| publicationDate |
2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007129418-A1 |
| titleOfInvention |
Ophthalmic compositions for treating ocular hypertension |
| abstract |
This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans. |
| priorityDate |
2002-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |